0001683168-21-006444.txt : 20211216
0001683168-21-006444.hdr.sgml : 20211216
20211216213659
ACCESSION NUMBER: 0001683168-21-006444
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211215
FILED AS OF DATE: 20211216
DATE AS OF CHANGE: 20211216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ziebell Mark R
CENTRAL INDEX KEY: 0001552642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 211499377
MAIL ADDRESS:
STREET 1: 14282 FRANKLIN AVENUE
CITY: TUSTIN
STATE: CA
ZIP: 92780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 2642 MICHELLE DRIVE, SUITE 200
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 2642 MICHELLE DRIVE, SUITE 200
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2021-12-15
0
0000704562
Avid Bioservices, Inc.
CDMO
0001552642
Ziebell Mark R
2642 MICHELLE DRIVE, SUITE 200
TUSTIN
CA
92780
0
1
0
0
V. P., General Counsel
Common Stock, $0.001 par value
2021-12-15
4
M
0
6429
3.2900
A
20687
D
Common Stock, $0.001 par value
2021-12-15
4
S
0
6429
24.5676
D
14258
D
Stock Option (right to buy)
3.2900
2021-12-15
4
M
0
6429
0.0000
D
2022-06-20
Common Stock
6429
286288
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2021.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $23.83 to $25.65. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Stock option granted to the reporting person on June 20, 2012 vested quarterly over a three (3) year period and was fully vested as of June 20, 2015.
/s/ Mark R. Ziebell
2021-12-16